Atlas Trials

Loiasis Cross-reactive Antigenemia and Treatment-related Adverse Events

Clinical trial NCT05085665 · COMPLETED

Trial details

NCT number
NCT05085665
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Loiasis
Start date
2021-07-30
Primary completion
2021-08-31
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.